Source: Fox News
Summary
Researchers at Stanford Medicine have developed a new vaccine that could prevent multiple viruses at once, including COVID-19, influenza, and pneumonia. The vaccine is administered intranasally through a nasal spray and provides broad protection in the lungs for several months. The study, published in the journal Science, found that the vaccine protected mice against various respiratory viruses and bacteria, including SARS-CoV-02 and other coronaviruses. The researchers claim this is the closest science has gotten to creating a universal vaccine that protects against respiratory viruses, bacteria, and allergens.
Our Reading
The advice sounds familiar. This guidance has been heard before, but it’s a new phase in the quest for a universal vaccine. Researchers have been working towards a single vaccine that protects against multiple viruses, and this study brings us closer to that goal. The nasal spray vaccine provides broad protection in the lungs, and the study found that it protected mice against various respiratory viruses and bacteria. The researchers are cautious, acknowledging that the study has limitations and that additional studies are needed to determine safety, optimal dosing, and effectiveness in people.
It’s a familiar pattern: a new study, a new vaccine, a new promise of protection. But will it be the solution we’re looking for? Only time and further research will tell.
Author: Evan Null
